期刊文献+

贝那普利对慢性充血性心力衰竭患者左心室及血管内皮功能的影响

Benazepril on left ventricular in patients with chronic congestive heart failure and vascular endothelial function
下载PDF
导出
摘要 目的探讨贝那普利对慢性充血性心力衰竭患者左心室及血管内皮功能的影响。方法选取268例慢性充血性心力衰竭,随机分为常规治疗组130例采取常规治疗,贝那普利组138例采取常规治疗联合贝那普利治疗,观察两组治疗前后血管内皮功能测定、左室舒张末内径(LVDd)、左心室射血分数(LVEF)并进行比较。结果两组治疗后FMD、左室舒张末内径、射血分数比较差异有统计学意义(P<0.05)。结论慢性充血性心力衰竭应用贝那普利可以有效的逆转左室重塑,改善左心室功能、血管内皮功能,改善血流动力学,减轻心力衰竭,改善患者的生活质量。 Objective To study benazepril on left ventricular in patients with chronic congestive heart failure and vascular endothelial function. Methods 268 cases were of chronic congestive heart failure randomly divided into conventional therapy to conventional treatment group 130 cases, 138 cases of benazepril group therapy combined with conventional shell was taken to Benazepril . Before and after treatment, endothelial function,left ventricular end diastolic diameter (LVDd), left ventricular ejection fraction (LVEF) were observed and compared.Results After treatment, FMD, left ventricular end diastolic diameter, ejection fraction.Conclusion The application of Benazepril can effectively reverse left ventricular remodeling and improve left ventricular function, endothelial function, improve hemodynamics, reduce heart failure and improve patient quality of life in chronic congestive heart failure.
作者 亓亚楠
出处 《中国实用医药》 2011年第3期11-12,共2页 China Practical Medicine
关键词 贝那普利 慢性充血性心力衰竭 左心室 血管内皮功能 Benazepril Chronic congestive heart failure Left ventricular Endothelial function
  • 相关文献

参考文献4

二级参考文献54

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2戴自英 陈灏珠 丁训杰.实用内科学[M](第9版)[M].北京:人民卫生出版社,1994.1221-1222.
  • 3陈灏珠 李宗明.内科学[M](第4版)[M].北京:人民卫生出版社,1997.136.
  • 4Gibert EM,Abraham WT,Olsen S,et al. Comarative hemodynamic left yentricular functional and antiadrenergic effects of chronic treatment with metoproloi versus cavedilio in the failing heart [J ]. Circulation, 1996,94 ( 12 ) : 2817 - 2825
  • 5MERIT - HF study Group. Effect of metrolol CR/CL in chronic heart failure;metrolol CR/CL rarndomlzed trial in congestive heart failure(MERIT - HF) [J]. Lancet, 1999,353(3) :2001 - 2007
  • 6Parker M,Coast M S, Hower MB, et al. Effect of Carvedi 101 on survival in severe chronic heart failure[J]. Nengl J Med,2001,344 (22) :1651 - 1658
  • 7Metavish D, Cempoli-Riehards D, Sorkin EM. Carvedilol: A review of its pharmaeodynamie and phareokinetie properties and therapeutic efficacy[J]. Drugs, 1993,45(2) :232 - 258
  • 8Bristow MR. Mechanism of action of beta-blocking agent in heart failure[J]. Am J Cardiol, 1997,80(4) :26 - 40
  • 9Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 10Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.

共引文献3684

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部